EUVIMEDEUVIMED entdecken
VergleichsstudieLeitlinieOpen Access · CC BY 4.0

Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines

Jan Gaertner, Christopher Boehlke, Gudrun Kreye, Tanja Fusi-Schmidhauser, Evelyn Mueller, Carmen Roch

Supportive Care in Cancer · 2024-07 · 32 (7)

DOI: 10.1007/s00520-024-08628-7 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 15.06.2024. Verfasst von Jan Gaertner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Palliative Care Center Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cancer Pain, Nausea, Vomiting. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Basel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We assumed that in Palliative Care, even in common clinical situations, the choice of drugs differs substantially between physicians. Therefore, we assessed the practice of pharmaceutical treatment choices of physicians for cancer pain and opioid-induced nausea and vomiting (OINV) and the rationale for their choices.

Methods

An online survey was conducted with physicians covering the following domains: i) Cancer pain therapy: non-opioids in addition to opioids: choice of drug ii) prevention of OINV: choice of drug and mode of application. Current guidelines concerning cancer pain therapy and prevention of OINV were compared.

Results

Two-hundred-forty European physicians responded to our survey. i) Use of non-opioids in addition to opioids for the treatment of cancer pain: Only 1.3% (n = 3) of respondents never used an additional non-opioid. Others mostly used: dipyrone/metamizole (49.2%, n = 118), paracetamol/acetaminophen (34.2%, n = 82), ibuprofen / other NSAIDs (11.3%, n = 27), specific Cox2-inhibitors (2.1%, n = 5), Aspirin (0.4%, n = 1), no answer (2.9%, n = 7). ii) Antiemetics to prevent OINV: The drugs of choice were metoclopramide (58.3%, n = 140), haloperidol (26.3%, n = 63), 5-HT3 antagonists (9.6%, n = 23), antihistamines (1.3%, n = 3) and other (2.9%, n = 7); no answer (1.7%, n = 4). Most respondents prescribed the substances on-demand (59.6%, n = 143) while others (36.3%, n = 87) provided them as around the clock medication. Over both domains, most physicians answered that their choices were not based on solid evidence from randomized controlled trials (RCTs). Guidelines were inconsistent regarding if and what non-opioid to use for cancer pain and recommend anti-dopaminergic drugs for prevention or treatment of OINV.

Conclusions

Physician’s practice in palliative care for the treatment of cancer pain and OINV differed substantially. Respondents expressed the lack of high-quality evidence- based information from RCTs. We call for evidence from methodologically high-quality RCTs to be available to inform physicians about the benefits and harms of pharmacological treatments for common symptoms in palliative care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidCancer PainNauseaVomitingPractice Guidelines as TopicPractice Patterns, Physicians'AntiemeticsHumansPalliative CareMaleEuropeHealth Care SurveysSurveys and QuestionnairesFemaleMiddle AgedAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

Opioid induced nausea and vomitingPain managementPalliative carePharmacological symptom controlSurvey

Substanzen

Analgesics, OpioidAntiemeticsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Palliative Care Center Basel, Basel, Switzerland.
  • Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Palliative Care Center Basel, Basel, Switzerland. christopher.boehlke@unibas.ch.
  • Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland. christopher.boehlke@unibas.ch.
  • Division of Palliative Care, Department of Internal Medicine, Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Karl Landsteiner University of Health Sciences, University Hospital, Krems, Austria.

Förderung

  • University of Basel

Zitieren

APA

Gaertner, J., Boehlke, C., Kreye, G., Fusi-Schmidhauser, T., Mueller, E., & Roch, C. (2024). Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines. Supportive Care in Cancer, 32(7). https://doi.org/10.1007/s00520-024-08628-7

Vancouver

Gaertner J, Boehlke C, Kreye G, Fusi-Schmidhauser T, Mueller E, Roch C. Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines. Supportive Care in Cancer. 2024;32(7). doi:10.1007/s00520-024-08628-7

BibTeX
@article{Gaertner2024,
  author = {Gaertner, Jan and Boehlke, Christopher and Kreye, Gudrun and Fusi-Schmidhauser, Tanja and Mueller, Evelyn and Roch, Carmen},
  title = {Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines},
  journal = {Supportive Care in Cancer},
  year = {2024},
  volume = {32},
  number = {7},
  doi = {10.1007/s00520-024-08628-7}
}
Kostenlos starten →